Heart Rate News and Research

RSS

Heart rate is determined by the number of heartbeats per unit of time, typically expressed as beats per minute (BPM), it can vary with as the body's need for oxygen changes, such as during exercise or sleep.

Fluke Biomedical receives RoHS E Environmentally-Friendly label for SPOT Light test device

Fluke Biomedical announced today the new ProSim SPOT Light SpO2 Functional Tester is the first biomedical test tool on the market to achieve the RoHS E Environmentally-Friendly label. Short for Restriction of Use of Hazardous Substances, RoHS regulations are designed to limit or eliminate substances that are dangerous to the environment and to people.

30 May 2012

Alpha-2 agonists decrease postoperative consumption of opioid drugs

A study from researchers at Geneva University Hospital, Geneva, Switzerland, provides evidence that use of alpha-2 agonists alongside opioids in surgical patients decreased opioid use by 25-30 percent. Even though opioid use was less, these patients reported slightly less pain after surgery.

25 May 2012

Optimi prototype effectively predicts people at risk of depression

The computing tool, developed by researchers at the Universitat Jaume I in Castellón, the Universitat Politècnica of València and the Universitat de València, along with professionals from the company everis, is able to predict if a person with a high-stress level is at risk of becoming depressed, based on the study of a series of physiological and psychological variables in which artificial intelligence techniques are used.

24 May 2012

Exercise can add years to a person's life

A recent study has shown that exercise can add years to a person's life. Still, as we age it can become more tedious and sometimes more difficult to exercise.

23 May 2012

Data from EarlySense contact-free monitor clinical study presented at ATS conference

EarlySense, a market leader in proactive patient care solutions, announced today the results of a clinical study conducted at a Dignity Health Hospital. The data was presented today in a poster presentation titled: Effect Of Contactless Continuous Patient Monitoring In A Medical-Surgical Unit On Intensive Care Unit Transfers: A Controlled Clinical Trial at the ATS International Conference in San Francisco.

22 May 2012

The Patient Status Engine™ – Industry’s First Cloud-Based Wireless Sensor Vigilance System for Real-time and Predictive Patient Status – Introduced by Isansys

Isansys Lifecare Limited, the provider of complete real-time physiological patient data services and systems, today announces the introduction of its Patient Status Engine™ – the first cloud-based patient digitization and analytic solution for monitoring and predicting the present and future clinical status of patients anytime, anywhere. The introduction of the Patient Status Engine provides the platform for Isansys’ “Vitals as a Service™” solution, which is now offered for priority beta deployments in hospitals and other healthcare facilities.

From Isansys Lifecare Ltd. 21 May 2012

Nordic walking enables heart failure patients to exercise more intensely

Nordic walking enables heart failure patients to exercise more intensely than walking without poles.

21 May 2012

Positive results from CardioKinetix Parachute system study on heart failure

CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced two-year clinical results for the first-of-its-kind catheter-based Parachute Ventricular Partitioning Device, a Percutaneous Ventricular Restoration (PVR) therapy for patients with ischemic heart failure.

19 May 2012

Researchers develop Bluetooth fetal heart rate monitoring system

Checking the heart of the unborn baby usually involves a stethoscope. However, an inexpensive and accurate Bluetooth fetal heart rate monitoring system has now been developed by researchers in India for long-term home care.

18 May 2012

Quasi-experimental data supports argument that air pollution may be a global risk factor for CVD

During the 2008 Beijing Olympics, changes in air pollution were associated with changes in biomarkers of systemic inflammation and thrombosis (formation of blood clot) as well as measures of cardiovascular physiology in healthy young persons, according to a study in the May 16 issue of JAMA, a theme issue on Global Health.

16 May 2012

Palpitations, hypertension strongest risk factors for AF

A large cohort study has found that the strongest risk factors for atrial fibrillation in both men and women were a history of palpitations and hypertension. While hypertension is a well known risk factor for AF, the investigators note that "the impact of self-reported palpitations on later occurrence of AF has not been documented earlier".

16 May 2012

New approach to advance quality of pregnancy monitoring

The University of California, San Diego Jacobs School of Engineering announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation. Bioengineering Professor Todd Coleman, in collaboration with Materials Science and Engineering Professor John A. Rogers at the University of Illinois at Urbana-Champaign, will pursue an innovative global health and development research project, titled "Epidermal Electronics for Continuous Pregnancy Monitoring."

10 May 2012

Caffeine consumption: How much is too much?

Chocolate, coffee and cola are perhaps three of your favourite consumables; however, they are also three caffeine-rich substances which all contribute to your daily caffeine consumption. According to the BBC, people should not exceed 400mg caffeine a day, and this limit halves for pregnant women, for which only 200mg/day is recommended.

10 May 2012

Discovery Labs reports data from SURFAXIN preclinical study on RDS

Discovery Laboratories, Inc., a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, reported that data from a preclinical study of SURFAXIN LS (lyophilized KL4 surfactant) was recently published in the May issue of Pediatric Research.

10 May 2012

People continue to make unhealthy choices despite best intentions

Humana Inc., one of the nation's leading health and well-being companies, and Reader's Digest, one of America's most recognized brands, today announced results of a nationwide survey that highlights an intriguing fact about health in America - despite our best intentions, Americans continue to make unhealthy choices.

7 May 2012

CardioKinetix Parachute Ventricular Partitioning Device trial data presented at 2012 EuroPCR

CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced that clinical trial data from the first-of-its-kind Parachute Ventricular Partitioning Device for the treatment of patients with ischemic heart failure will be presented at the 2012 EuroPCR Conference in Paris.

7 May 2012

Aspirin versus warfarin for heart failure patients

In a new study on more than 2,000 patients, published in the New England Journal of Medicine, researchers found that aspirin was as effective as the commonly prescribed drug warfarin. It said each drug had risks, but they had similar benefits overall.

4 May 2012

Removing email from workers' lives reduces stress and boosts productivity

Being cut off from work email significantly reduces stress and allows employees to focus far better, according to a new study by UC Irvine and U.S. Army researchers.

4 May 2012

Physician Therapeutics publishes results from Sentra PM clinical trial

Physician Therapeutics, Inc., a division of Targeted Medical Pharma, Inc., a specialty pharmaceutical company that manufactures and distributes specialty pharmaceuticals to physicians, pharmacies and skilled nursing facilities, published results from a clinical trial of the proprietary medical food Sentra PM.

3 May 2012

Kauffman Foundation sponsors National Conference on Value-driven Engineering

Researchers, health care engineers and medical device experts gathered this week for the inaugural National Conference on Value-driven Engineering to Improve Medical Innovation for U.S. Global Competitiveness assembled by the Austen BioInnovation Institute in Akron (ABIA) and sponsored by the Ewing Marion Kauffman Foundation.

30 Apr 2012